174 related articles for article (PubMed ID: 8210064)
1. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study].
Michalak A; Qureshi IA
Ann Biol Clin (Paris); 1993; 51(10-11):879-85. PubMed ID: 8210064
[TBL] [Abstract][Full Text] [Related]
2. [Carnitine levels in muscle in mice with hyperammonemia: effect of treatment with sodium benzoate].
Michalak A; Qureshi IA
Can J Physiol Pharmacol; 1993 Jul; 71(7):439-46. PubMed ID: 8242478
[TBL] [Abstract][Full Text] [Related]
3. Tissue acylcarnitine and acyl-coenzyme A profiles in chronically hyperammonemic mice treated with sodium benzoate and supplementary L-carnitine.
Michalak A; Qureshi IA
Biomed Pharmacother; 1995; 49(7-8):350-7. PubMed ID: 8562862
[TBL] [Abstract][Full Text] [Related]
4. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
Ratnakumari L; Qureshi IA; Butterworth RF
Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
Ratnakumari L; Qureshi IA; Butterworth RF
Biochem Pharmacol; 1993 Jan; 45(1):137-46. PubMed ID: 8424807
[TBL] [Abstract][Full Text] [Related]
6. Development and inducibility of the hepatic and renal hippurate-synthesizing system in sparse-fur (spf) mutant mice with ornithine transcarbamylase deficiency.
Qureshi IA; Lebel S; Letarte J
Biochem Int; 1989 Sep; 19(3):657-66. PubMed ID: 2818615
[TBL] [Abstract][Full Text] [Related]
7. Significance of transported glycine in the conjugation of sodium benzoate in spf mutant mice with ornithine transcarbamylase deficiency.
Qureshi I; Rouleau T; Letarte J; Ouellet R
Biochem Int; 1986 Jun; 12(6):839-46. PubMed ID: 3091026
[TBL] [Abstract][Full Text] [Related]
8. Free and esterified coenzyme A in the liver and muscles of chronically hyperammonemic mice treated with sodium benzoate.
Michalak A; Qureshi IA
Biochem Mol Med; 1995 Apr; 54(2):96-104. PubMed ID: 8581365
[TBL] [Abstract][Full Text] [Related]
9. Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment.
Michalak A; Qureshi IA
Biochem Med Metab Biol; 1990 Apr; 43(2):163-74. PubMed ID: 2346672
[TBL] [Abstract][Full Text] [Related]
10. Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine.
Ratnakumari L; Qureshi IA; Maysinger D; Butterworth RF
J Pharmacol Exp Ther; 1995 Jul; 274(1):437-43. PubMed ID: 7616428
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.
Batshaw ML; Hyman SL; Coyle JT; Robinson MB; Qureshi IA; Mellits ED; Quaskey S
Pediatr Res; 1988 Apr; 23(4):368-74. PubMed ID: 3374991
[TBL] [Abstract][Full Text] [Related]
12. [Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
Michalak A; Lambert MA; Dallaire L; Melançon SB; Laframboise R; Lemieux B; Qureshi IA
Diabete Metab; 1990; 16(3):226-33. PubMed ID: 2210018
[TBL] [Abstract][Full Text] [Related]
13. Alteration of urinary carnitine profile induced by benzoate administration.
Sakuma T
Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
[TBL] [Abstract][Full Text] [Related]
14. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
[TBL] [Abstract][Full Text] [Related]
15. Effects of fibrates on the glycine conjugation of benzoic acid in rats.
Gregus Z; Fekete T; Halászi E; Gyurasics A; Klaassen CD
Drug Metab Dispos; 1998 Nov; 26(11):1082-8. PubMed ID: 9806950
[TBL] [Abstract][Full Text] [Related]
16. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
[TBL] [Abstract][Full Text] [Related]
17. Benzoic acid metabolism reflects hepatic mitochondrial function in rats with long-term extrahepatic cholestasis.
Krähenbühl L; Reichen J; Talos C; Krähenbühl S
Hepatology; 1997 Feb; 25(2):278-83. PubMed ID: 9021934
[TBL] [Abstract][Full Text] [Related]
18. Activity of the glycine cleavage system in hyperammonemia treated with benzoate.
Kodama H; Fujiwara K; Motokawa Y; Tajiri H; Nose O; Kamoshita S
Tohoku J Exp Med; 1983 Jul; 140(3):337-8. PubMed ID: 6623463
[TBL] [Abstract][Full Text] [Related]
19. Benzoyl-CoA ligase activity in the liver and kidney cortex of weanling guinea pigs treated with various inducers: relationship with hippurate synthesis and carnitine levels.
Ali A; Qureshi IA
Dev Pharmacol Ther; 1992; 18(1-2):55-64. PubMed ID: 1483363
[TBL] [Abstract][Full Text] [Related]
20. Availability of glycine and coenzyme A limits glycine conjugation in vivo.
Gregus Z; Fekete T; Varga F; Klaassen CD
Drug Metab Dispos; 1992; 20(2):234-40. PubMed ID: 1352215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
